- Since being established in 2013, The Perth Blood Institute Limited has become one of the fastest growing haematology research organisations in Australia, with a focus on providing outstanding patient care with an ethical and sustainable approach.
- The Perth Blood Institute Limited is a charitable, not for profit research institute with membership from various disciplines including clinical haematology, clinical pharmacy, nursing, allied health and clinical research staff who are involved in the care of people diagnosed with blood conditions, including blood cancers, bleeding and clotting disorders.
- The care of people with blood disorders is complex and has long been a focus of many clinicians and support staff who work with The Perth Blood Institute Limited. An integral part of providing the highest standard of care to people diagnosed with blood disorders is the ability to involve them in ‘state of the art’ clinical trials and translational research.
- Clinical trials in particular can offer people with blood disorders the most up to date treatment options, which have been developed through extensive clinical research.
- As the largest haematology clinical research centre in Western Australia, we are pleased to invite you to support us to conduct high quality research in all aspects of blood disorder management and establish inititatives which will broaden the access to safe and effective treatment options for patients and their families.
Our Goal/Mission
- Conduct medical research into blood disorders, including their causes, prevention and treatment options
- Facilitate access to high quality clinical trials for people affected by blood disorders
- Improve the provision of information about blood disorders to patients and their families
Our Team
Professor Ross Baker
MBBS BMedSc FRACP FACP FRCPA
Professor Ross Baker is currently:
His major interest is the translation of new scientific discoveries into clinical haematology practice.
As Principal Investigator in, more than 95 large international phase II and III clinical trials, he has actively led and participated in clinical research in venous thrombosis, leukaemia, lymphoma, myeloma, thrombocytopenia Von Willebrand disease and haemophilia. Since 1992 he has authored over 100 papers in peer reviewed journals and has been a regularly invited speaker at national and international haematology and medical meetings. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis (ASTH) and scientific advisor to the World Health Organisation on DVT in 2001.
His professional memberships include the Haematology Society of Australia and New Zealand, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Australian Haemophilia Centre Directors Organisation (AHCDO), International Society Thrombosis and Haemostasis, American Society of Haematology, Australian Leukaemia and Lymphoma Study Group, and the Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC),
He is also past President of the Australasian Society Thrombosis Haemostasis from 1997 to 2001, Haematology Advisory member of the Royal Australasian College of Pathologists 1998 to 2003 and Councillor for the Haematology Society of Australia and New Zealand from 1992 to 1999.
He currently is an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Australasian Society of Thrombosis Haemostasis (ASTH) new oral anticoagulant Reversal and Event Collaborative (ARES), Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Perth Blood Institute and the executive committee for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019.
He has extensive clinical and laboratory experience in a wide range of haematological disorders and has been a consultant in haematology for over 20 years.
MBBS BMedSc FRACP FACP FRCPA
Professor Ross Baker is currently:
- Senior Consultant Haematologist - Hollywood Hospital
- Director, WA Centre for Thrombosis and Haemostasis, Murdoch University
- Director, Haemophilia Treatment Centre - Hollywood Hospital
- Chairman, Perth Blood Institute
His major interest is the translation of new scientific discoveries into clinical haematology practice.
As Principal Investigator in, more than 95 large international phase II and III clinical trials, he has actively led and participated in clinical research in venous thrombosis, leukaemia, lymphoma, myeloma, thrombocytopenia Von Willebrand disease and haemophilia. Since 1992 he has authored over 100 papers in peer reviewed journals and has been a regularly invited speaker at national and international haematology and medical meetings. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis (ASTH) and scientific advisor to the World Health Organisation on DVT in 2001.
His professional memberships include the Haematology Society of Australia and New Zealand, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Australian Haemophilia Centre Directors Organisation (AHCDO), International Society Thrombosis and Haemostasis, American Society of Haematology, Australian Leukaemia and Lymphoma Study Group, and the Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC),
He is also past President of the Australasian Society Thrombosis Haemostasis from 1997 to 2001, Haematology Advisory member of the Royal Australasian College of Pathologists 1998 to 2003 and Councillor for the Haematology Society of Australia and New Zealand from 1992 to 1999.
He currently is an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Australasian Society of Thrombosis Haemostasis (ASTH) new oral anticoagulant Reversal and Event Collaborative (ARES), Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Perth Blood Institute and the executive committee for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019.
He has extensive clinical and laboratory experience in a wide range of haematological disorders and has been a consultant in haematology for over 20 years.
Dr Peter Tan
MBBS (Hons) FRACP FRCPA
Clinical Trials Director, Consultant Haematologist
Dr Peter Tan is a consultant haematologist with a particular research interest in haematological malignancies, including acute myeloid leukaemia. Dr Tan is the Director of the Clinical Trials Unit at Perth Blood Institute, where he is the principal or co-investigator on numerous clinical trials. He is also an investigator with the Australasian Leukaemia & Lymphoma Group, where he is the co-principal investigator for the study entitled ‘A strategy of high-dose lenalidomide in combination with epigenetic therapies for relapsed and refractory AML (ALLG AML M17)’.
MBBS (Hons) FRACP FRCPA
Clinical Trials Director, Consultant Haematologist
Dr Peter Tan is a consultant haematologist with a particular research interest in haematological malignancies, including acute myeloid leukaemia. Dr Tan is the Director of the Clinical Trials Unit at Perth Blood Institute, where he is the principal or co-investigator on numerous clinical trials. He is also an investigator with the Australasian Leukaemia & Lymphoma Group, where he is the co-principal investigator for the study entitled ‘A strategy of high-dose lenalidomide in combination with epigenetic therapies for relapsed and refractory AML (ALLG AML M17)’.
Scott McGregor
BPharm (Hons) PGradDipPharm MSHP
Executive Officer, Clinical Trials Unit Manager
Scott McGregor is a registered pharmacist with extensive experience in clinical trials and oncology pharmacy services. Scott is the Executive Officer and General Manager - Clinical Research at the Perth Blood Institute. Scott is also a consultant haematology pharmacist at Perth Blood Institute and Haematology West.
BPharm (Hons) PGradDipPharm MSHP
Executive Officer, Clinical Trials Unit Manager
Scott McGregor is a registered pharmacist with extensive experience in clinical trials and oncology pharmacy services. Scott is the Executive Officer and General Manager - Clinical Research at the Perth Blood Institute. Scott is also a consultant haematology pharmacist at Perth Blood Institute and Haematology West.
Adriana Filippou
Public Relations & Communications |
Julie Robinson
Clinical Trial Unit Manager/Start-up Specialist |
Megan Margaria
Senior Clinical Trial Co-ordinator/Nurse |
Shilpa Rakesh
Research Resident Medical Practitioner |
Neelam Samnakay
Phlebotomist, Western Diagnostic Pathology |
Vanessa Dumouchel
Clinical Trials Coordinator /Start-up Specialist |
Jacey (JiSeaon) Jeong
Clinical Trials Assistant/Coordinator |
Sarah Murray
Clinical Trials Coordinator/Nurse |
Our Ambassador - Shelley Taylor-Smith
Shelley Taylor-Smith
Another way of showing support for The Perth Blood Institute is by becoming an Ambassador.
We are always seeking to increase community awareness of our purpose with people diagnosed with blood disorders and blood conditions.
The Perth Blood Institute is proud to announce Shelley Taylor-Smith as Ambassador. Shelley represents The Perth Blood Institute at community events and workplaces, leading teams and projects and promoting and championing our Mission. Shelley also communicates and generates awareness of our Purpose within the local community that blood disorders can happen to anybody, at any age, at any time, with no real warning!
Together with Shelley, we are able to strengthen partnerships for the benefit of improving the health of the community. Shelley’s support will enable us to provide care, welfare, education and support to our patients and their families. Our purpose is to provide the highest standard of care for people diagnosed with blood disorders and blood cancers and the ability to involve them in ‘state of the art’ clinical trials and translational research and access to new treatments.
We thank Shelley who has helped raise awareness and funds for The Perth Blood Institute, as well as her support in assisting us to achieve and provide information, inspiration and opportunity to so many people with blood disorders and blood conditions.
Shelley’s achievements..
Regardless of being tagged with ‘no natural ability, disabled and nothing above average’ 7-time World No. 1 Women’s Marathon Swimming champion Shelley is the only woman to achieve No. 1 world ranking for both men and women in the history of any sport worldwide.
Nicknamed ‘Dangerous when Wet’ by her competitors (and apt title of her biography) Shelley’s greatest personal achievement is not a title or an award. It is the result of her achieving the No. 1 world ranking that led to the international swimming governing body, FINA creating equal prize money and separate rankings for both genders, that is, her global legacy for women.
Shelley gives back as Ambassador, Board member for the Swan River Trust and Burswood Park whilst also serving as advisory consultant for Swimming Australia Limited and Swimming WA. Her lastest project ‘The Feminine Code’ helps women achieve their desired feminine potential, power and performance.
Shelley Taylor-Smith has rewritten the record books and set new standards in one of the roughest sports imaginable – marathon swimming. Seven consecutive world titles, a world championship gold medal and head to head victories over the best men in the sport have marked her as one one the supreme athletes of the 1980’s & 1990’s. On her triumphant march through a career spanning twelve years, she has earned a place in the Guinness Book of Records for the fastest swim (male or female) around New York’s Manhatton Island and captivated Australia with her record shattering swim from Sydney to Woollongong..and she hasn’t finished yet!
Shelley has shared her story in a book ‘Dangerous When Wet’ from her memories growing up in Perth to her drama filled reclamation of the ‘round Manhattan’ record. The book is spirited, uncompromising and right from the heart, like Shelley! Behind her rise to success, life dealt Shelley some heavy blows which are captivated in a riveting story of an amazing woman’s life. Above all, ‘Dangerous When Wet’ is about belief in oneself, triumph over adversity and the power of positive thinking!
We are always seeking to increase community awareness of our purpose with people diagnosed with blood disorders and blood conditions.
The Perth Blood Institute is proud to announce Shelley Taylor-Smith as Ambassador. Shelley represents The Perth Blood Institute at community events and workplaces, leading teams and projects and promoting and championing our Mission. Shelley also communicates and generates awareness of our Purpose within the local community that blood disorders can happen to anybody, at any age, at any time, with no real warning!
Together with Shelley, we are able to strengthen partnerships for the benefit of improving the health of the community. Shelley’s support will enable us to provide care, welfare, education and support to our patients and their families. Our purpose is to provide the highest standard of care for people diagnosed with blood disorders and blood cancers and the ability to involve them in ‘state of the art’ clinical trials and translational research and access to new treatments.
We thank Shelley who has helped raise awareness and funds for The Perth Blood Institute, as well as her support in assisting us to achieve and provide information, inspiration and opportunity to so many people with blood disorders and blood conditions.
Shelley’s achievements..
Regardless of being tagged with ‘no natural ability, disabled and nothing above average’ 7-time World No. 1 Women’s Marathon Swimming champion Shelley is the only woman to achieve No. 1 world ranking for both men and women in the history of any sport worldwide.
Nicknamed ‘Dangerous when Wet’ by her competitors (and apt title of her biography) Shelley’s greatest personal achievement is not a title or an award. It is the result of her achieving the No. 1 world ranking that led to the international swimming governing body, FINA creating equal prize money and separate rankings for both genders, that is, her global legacy for women.
Shelley gives back as Ambassador, Board member for the Swan River Trust and Burswood Park whilst also serving as advisory consultant for Swimming Australia Limited and Swimming WA. Her lastest project ‘The Feminine Code’ helps women achieve their desired feminine potential, power and performance.
Shelley Taylor-Smith has rewritten the record books and set new standards in one of the roughest sports imaginable – marathon swimming. Seven consecutive world titles, a world championship gold medal and head to head victories over the best men in the sport have marked her as one one the supreme athletes of the 1980’s & 1990’s. On her triumphant march through a career spanning twelve years, she has earned a place in the Guinness Book of Records for the fastest swim (male or female) around New York’s Manhatton Island and captivated Australia with her record shattering swim from Sydney to Woollongong..and she hasn’t finished yet!
Shelley has shared her story in a book ‘Dangerous When Wet’ from her memories growing up in Perth to her drama filled reclamation of the ‘round Manhattan’ record. The book is spirited, uncompromising and right from the heart, like Shelley! Behind her rise to success, life dealt Shelley some heavy blows which are captivated in a riveting story of an amazing woman’s life. Above all, ‘Dangerous When Wet’ is about belief in oneself, triumph over adversity and the power of positive thinking!
Our Partners
|
|
|
|
|
|
|
|
|